The safety of incretin based drug treatments for type 2 diabetes.
作者信息
Bolen Shari D, Maruthur Nisa M
机构信息
Division of General Internal Medicine, Department of Medicine, The MetroHealth System/Case Western Reserve University, Cleveland, OH, USA Department of Epidemiology and Biostatistics, Case Western Reserve University
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, MD, USA.
出版信息
BMJ. 2016 Feb 17;352:i801. doi: 10.1136/bmj.i801.
DOI:10.1136/bmj.i801
PMID:26888024
Abstract
摘要
相似文献
1
The safety of incretin based drug treatments for type 2 diabetes.基于肠促胰岛素的2型糖尿病药物治疗的安全性。
BMJ. 2016 Feb 17;352:i801. doi: 10.1136/bmj.i801.
2
The safety of incretin based drugs.基于肠促胰岛素的药物的安全性。
BMJ. 2014 Apr 24;348:g2779. doi: 10.1136/bmj.g2779.
3
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.基于肠促胰岛素的降糖药物与急性胰腺炎和/或胰腺癌风险：心血管结局试验的可靠数据
Diabetes Obes Metab. 2017 Sep;19(9):1327-1328. doi: 10.1111/dom.12981. Epub 2017 May 22.
4
ACP Journal Club. Incretin use was not associated with increased risk for acute pancreatitis.《美国内科医师学会杂志俱乐部》。使用肠促胰岛素与急性胰腺炎风险增加无关。
Ann Intern Med. 2015 Jun 16;162(12):JC12. doi: 10.7326/ACPJC-2015-162-12-012.
5
Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.基于肠促胰岛素的药物与胰腺癌风险：国际多中心队列研究
BMJ. 2016 Feb 17;352:i581. doi: 10.1136/bmj.i581.
6
[Cardiovascular safety of incretin-based antidiabetic treatment - results of completed clinical trials].基于肠促胰岛素的抗糖尿病治疗的心血管安全性——已完成临床试验的结果
Orv Hetil. 2016 Apr 17;157(16):603-10. doi: 10.1556/650.2016.30416.
7
Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098.对汤姆森等人的评论。基于肠促胰岛素的治疗与急性胰腺炎风险：一项基于全国人群的病例对照研究。《糖尿病护理》2015年；38:1089 - 1098。
Diabetes Care. 2015 Jul;38(7):e106-7. doi: 10.2337/dc15-0367.
8
Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?问：用于2型糖尿病的肠促胰岛素药物会增加急性胰腺炎的风险吗？
Cleve Clin J Med. 2010 Aug;77(8):503-5. doi: 10.3949/ccjm.77a.09167.
9
Response to Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098.对关于汤姆森等人的评论的回应。基于肠促胰岛素的治疗与急性胰腺炎风险：一项基于全国人口的病例对照研究。《糖尿病护理》2015年；38:1089 - 1098。
Diabetes Care. 2015 Jul;38(7):e108-9. doi: 10.2337/dc15-0675.
10
Incretin-based therapies are associated with acute pancreatitis: Meta-analysis of large randomized controlled trials.基于肠降血糖素的治疗与急性胰腺炎相关：大型随机对照试验的荟萃分析。
Diabetes Res Clin Pract. 2015 Dec;110(3):e13-7. doi: 10.1016/j.diabres.2015.10.014. Epub 2015 Oct 23.
引用本文的文献
1
Computational Analysis of Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor.作为二肽基肽酶-IV抑制剂的生物活性化合物的计算分析
Adv Bioinformatics. 2017;2017:5124165. doi: 10.1155/2017/5124165. Epub 2017 Aug 8.
Zotero 插件